A carregar...
Prospective study of mobilization kinetics up to 18 hours after late afternoon dosing of plerixafor
BACKGROUND: The current FDA-approved time interval between plerixafor dosing and apheresis initiation is ~ 11 hours, but this time interval is impractical for most care providers. Few studies have examined mobilization kinetics beyond 11 hours in multiple myeloma (MM) and non-Hodgkin’s lymphoma (NHL...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3989464/ https://ncbi.nlm.nih.gov/pubmed/24128272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.12459 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|